Show simple item record

dc.contributor.authorKara, Cengiz
dc.contributor.authorGunindi, Figen
dc.contributor.authorUstyol, Ala
dc.contributor.authorAydin, Murat
dc.date.accessioned2020-06-21T13:59:28Z
dc.date.available2020-06-21T13:59:28Z
dc.date.issued2014
dc.identifier.issn0031-4005
dc.identifier.issn1098-4275
dc.identifier.urihttps://doi.org/10.1542/peds.2013-0711
dc.identifier.urihttps://hdl.handle.net/20.500.12712/15501
dc.descriptionAYDIN, MURAT/0000-0001-7374-229Xen_US
dc.descriptionWOS: 000329168400029en_US
dc.descriptionPubMed: 24298009en_US
dc.description.abstractPediatric cases of vitamin D intoxication (VDI) with dietary supplements have not been previously reported. We report on 7 children with VDI caused by consumption of a fish oil supplement containing an excessively high dose of vitamin D due to a manufacturing error. Seven children aged between 0.7 and 4.2 years were admitted with symptoms of hypercalcemia. Initial median (range) serum concentrations of calcium and 25-hydroxyvitamin D were 16.5 (13.4-18.8) mg/dL and 620 (340-962) ng/mL, respectively. Repeated questioning of the parents revealed use of a fish oil that was produced recently by a local manufacturer. Analysis of the fish oil by gas chromatography/mass spectrometry revealed that the vitamin D-3 content was similar to 4000 times the labeled concentration. Estimated daily amounts of vitamin D-3 intake varied between 266 000 and 800 000 IU. Patients were successfully treated with intravenous hydration, furosemide, and pamidronate infusions. With treatment, serum calcium returned to the normal range within 3 days (range: 2-7 days). Serum 25-hydroxyvitamin D levels normalized within 2 to 3 months. Complications, including nephrocalcinosis, were not observed throughout the 1-year follow-up. In conclusion, errors in manufacturing of dietary supplements may be a cause of VDI in children. Physicians should be aware of this possibility in unexplained VDI cases and repeatedly question the families about dietary supplement use. To prevent the occurrence of such unintentional incidents, manufacturers must always monitor the levels of ingredients of their products and should be rigorously over-seen by governmental regulatory agencies, as is done in the pharmaceutical industry.en_US
dc.language.isoengen_US
dc.publisherAmer Acad Pediatricsen_US
dc.relation.isversionof10.1542/peds.2013-0711en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectbisphosphonatesen_US
dc.subjectfish oilsen_US
dc.subjecthypercalcemiaen_US
dc.subjectover-the-counter drugsen_US
dc.subjectvitamin Den_US
dc.titleVitamin D Intoxication Due to an Erroneously Manufactured Dietary Supplement in Seven Childrenen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume133en_US
dc.identifier.issue1en_US
dc.identifier.startpageE240en_US
dc.identifier.endpageE244en_US
dc.relation.journalPediatricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record